Table 4.
Relationship between the expression of IL-6, IL-8, IL-10 protein and clinicopathological factors in malignant CMGTs tissue.
| Characteristics | n | IL-6 | IL-8 | IL-10 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | χ2 | P | n (%) | χ2 | P | n (%) | χ2 | P | ||
| Years | ||||||||||
| ≤ 8 | 18 | 10 (55.56%) | 1.728 | 0.189 | 12 (66.67%) | 1.631 | 0.202 | 6 (33.33%) | 1.821 | 0.177 |
| > 8 | 34 | 25 (73.53%) | 28 (82.35%) | 18 (52.94%) | ||||||
| Size (cm) | ||||||||||
| T1(< 3) | 8 | 3 (37.5%) | 5.017 | 0.081 | 6 (75%) | 0.223 | 0.894 | 4 (50%) | 0.139 | 0.933 |
| T2(3 ≤ T ≤ 5) | 27 | 22 (78.57%) | 23 (82.14%) | 12 (42.85%) | ||||||
| T3((> 5) | 17 | 10 (71.42%) | 11 (78.57%) | 6 (42.85%) | ||||||
| Node state | ||||||||||
| Yes | 12 | 11 (91.67%) | 4.207 | *0.040 | 8 (66.67%) | 0.924 | 0.336 | 7 (58.33%) | 1.641 | 0.200 |
| No | 40 | 24 (60%) | 32 (80%) | 15 (37.5%) | ||||||
| Histologic grade | ||||||||||
| I | 16 | 6 (37.5%) | 6.888 | *0.032 | 9 (56.25%) | 6.816 | 0.033 | 5 (31.25% | 2.068 | 0.356 |
| II | 24 | 19 (79.16%) | 22 (91.67%) | 10 (41.67%) | ||||||
| III | 12 | 10 (83.33%) | 9 (75%) | 7 (58.33%) | ||||||
| Molecular subtype | ||||||||||
| Luminal A | 14 | 8 (57.14%) | 9.053 | *0.029 | 12 (85.71%) | 10.31 | *0.016 | 5 (35.71% | 3.57 | 0.312 |
| Luminal B | 24 | 19 (79.16%) | 21 (87.5%) | 14 (58.33%) | ||||||
| Her-2 positive | 8 | 2 (25%) | 3 (37.5%) | 2 (25%) | ||||||
| Basal-like | 6 | 5 (83.33%) | 4 (66.67%) | 2 (33.33%) | ||||||
*P < 0.05 was considered to be statistically significant.